Facebook's advertising machine was one of the most efficient money-making operations in the history of the world. Until last year, that is, when... Read More...
Reuters
Lawsuit over Pfizer’s disclosures before Chantix recall is dismissed
A federal judge on Wednesday dismissed a proposed class action lawsuit by consumers who accused Pfizer Inc of failing to disclose the presence of cancer-causing agents in Chantix before recalling the anti-smoking drug. U.S. District Judge Denise Cote in Manhattan found no plausible allegations that Pfizer had a duty to disclose that Chantix was contaminated by a type of carcinogen known as a nitrosamine, or was unfit to help consumers quit smoking. Plaintiffs Roslyn Harris, of Jersey City, New Jersey, and Mary Allen, of Warrensburg, New York, claimed that Chantix was “worthless” because of the contamination, and that they would not have bought the drug had they known about it.
